NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
04/10/2026
Back to search
Official data from USPTO
CIPLA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
04/11/2026
Trademark type
Word
Nice classes
5
Filing date
10/26/2018
Registration date
10/29/2019
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/10/2026
Last transaction
04/11/2026
Responsible office
United States Patent and Trademark Office
Status code
701
Official register
Principal Register
Drawing code
4
Owner type
03
Owner location
Mumbai, Maharashtra, IN
Examiner
NITKIN, DINISHA F
Current location
Historical data usage
Holders and representatives
Holders
CIPLA LIMITED
Representatives
Stacey R. Halpern Knobbe, Martens, Olson & Bear, LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical and medicinal preparations for the treatmentalleviation and prevention of gastro-intestinal disordersdisorders of the central nervous systemencephalitisepilepsyAlzheimer'scerebral palsyParkinson's diseaseseizures Huntington's diseasemultiple sclerosis; Pharmaceutical and medicinal preparations for the treatmentalleviation and prevention of disorders of the respiratory systemheart conditions and other disorders of the cardiovascular systemCoronary artery diseaseHeart attackabnormal heart rhythmsarrhythmiasheart failureheart valve diseasecongenital heart diseasecardiomyopathypericardial disease; Pharmaceutical and medicinal preparations for the treatmentalleviation and prevention of migraines and other forms of headachesinus headachestension headachescluster headaches and rebound headaches; pharmaceutical and medicinal preparationsanalgesics; pharmaceutical and medicinal preparationsantiviral and anti-retroviral pharmaceutical preparations for the treatment of viral brain diseases; pharmaceutical and medicinal preparationsanti-infectives; pharmaceutical and medicinal preparationsanti-inflammatories; pharmaceutical and medicinal preparationsantibiotics; pharmaceutical and medicinal preparationsantidepressants; pharmaceutical and medicinal preparationsanti-cancer preparations; pharmaceutical and medicinal preparationsmedicated soaps and lotions for the skin and hairmedicated acne lotionmedicated body moisturizing lotionmedicated lotion for eczema and seborrheic dermatitismedicated hair shampoo and hair scalp lotionmedicated anti-dandruff lotion; pharmaceutical and medicinal preparationsdecongestants and antihistamines; pharmaceutical and medicinal preparationsscabicides; pharmaceutical and medicinal preparationsanti-malarials; pharmaceutical and medicinal preparationscough suppressants; pharmaceutical and medicinal preparationscough and cold preparations; pharmaceutical and medicinal preparationsexpectorants; pharmaceutical and medicinal preparationsanti-leukemic agents; pharmaceutical and medicinal preparationstissue sealants; pharmaceutical and medicinal preparationsvasopressors; pharmaceutical and medicinal preparationsnondepolarizing skeletal neuromuscular blocking agents; pharmaceutical and medicinal preparationspreparations for the treatment of gout; pharmaceutical and medicinal preparationspreparations for cessation of smoking; Pharmaceutical and medicinal preparations for the treatmentalleviation and prevention of genitourinary diseases and disordersurological diseasesurological disordersurinary incontinenceinfertilitysexually transmitted diseasesinflammatory pelvic diseases; Pharmaceutical and medicinal preparations for the treatmentalleviation and prevention of pain from burnshemolytic diseases and disordersneuropathic pain; Pharmaceutical and medicinal preparations for the treatmentalleviation and prevention of fibromyalgiapost-herpetic neuralgiachronic painobesityinflammation and inflammatory diseasesinflammatory bowel diseasesinflammatory connective tissue diseasesimmunological diseases and disordersautoimmune diseasesimmunologic deficiency syndromesAcquired Immune Deficiency Syndrome (AIDS)viral diseases and disordersherpeshepatitissubstance abuse disordersalcoholism and drug addictioncarpel tunnel syndromevaricose veinsdental and oral diseasesosteoporosisarthritisyeast infectionsprostate disorderspulmonary disorderssleep disordersinsomnia andrestless leg syndromepremature ejaculationmacular degenerationthrombosis and thromboembolism; pharmaceutical and medicinal preparationsvaccines for human use; pharmaceutical and medicinal preparationsadjuvants for use with human vaccines; pharmaceutical and medicinal preparations in the nature of veterinary preparationsflea and tick preparationsvaccinesanti inflammatoriesmastitis preparationsoncological preparations
Publications
History of USPTO decisions and trademark events.
24 publications found
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
04/10/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
03/20/2026
ES8R
TEAS SECTION 8 RECEIVED
10/29/2025
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/29/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
10/29/2019
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/13/2019
PUBO
PUBLISHED FOR OPPOSITION
08/13/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/24/2019
ALIE
ASSIGNED TO LIE
07/08/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/27/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
06/27/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
06/27/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
06/27/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
06/27/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/07/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/06/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/06/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/04/2019
GNRT
NON-FINAL ACTION E-MAILED
02/04/2019
CNRT
NON-FINAL ACTION WRITTEN
02/04/2019
DOCK
ASSIGNED TO EXAMINER
02/04/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/09/2018
NWAP
NEW APPLICATION ENTERED
10/30/2018
Continuous trademark protection
Get notified about every new filing that threatens CIPLA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.